Lohéac Charlotte, Aubert Olivier, Loupy Alexandre, Legendre Christophe
Service de transplantation rénale, hôpital Necker-Enfants-malades, 149, rue de Sèvres, 75015 Paris, France; Université Paris Descartes, 75006 Paris, France.
Service de transplantation rénale, hôpital Necker-Enfants-malades, 149, rue de Sèvres, 75015 Paris, France; Université Paris Descartes, 75006 Paris, France.
Nephrol Ther. 2018 Apr;14 Suppl 1:S39-S50. doi: 10.1016/j.nephro.2018.02.018.
Results of kidney transplantation have been improving but long-term allograft survival remains disappointing. The objective of the present study was to identify the specific causes of renal allograft loss, to assess their incidence and long-term outcomes.
A total of 4783 patients from four French centres, transplanted between January 2004 and January 2014 were prospectively included. A total of 9959 kidney biopsies (protocol and for cause) performed between January 2004 and March 2015 were included. Donor and recipient clinical and biological parameters as well as anti-HLA antibody directed against the donor were included. The main outcome was the long-term kidney allograft survival, including the study of the associated causes of graft loss, the delay of graft loss according to their causes and the determinants of graft loss.
There were 732 graft losses during the follow-up period (median time: 4.51 years) with an identified cause in 95.08 %. Kidney allograft survival at 9 years post-transplant was 78 %. The causes of allograft loss were: antibody-mediated rejection (31.69 %), thrombosis (25.55 %), medical intercurrent disease (14.62 %), recurrence of primary renal disease (7.1 %), BK- or CMV-associated nephropathy (n=35, 4.78 %), T cell-mediated rejection (4.78 %), urological disease (2.46 %) and calcineurin inhibitor nephrotoxicity (1.09 %).
The main causes of allograft loss were antibody-mediated rejection and thrombosis. These results encourage efforts to prevent and detect these complications earlier in order to improve allograft survival.
肾移植的结果一直在改善,但长期同种异体肾移植存活率仍然令人失望。本研究的目的是确定肾移植失败的具体原因,评估其发生率和长期结果。
前瞻性纳入了2004年1月至2014年1月间在法国四个中心接受移植的4783例患者。纳入了2004年1月至2015年3月间进行的9959例肾活检(方案活检和病因活检)。纳入了供体和受体的临床及生物学参数以及针对供体的抗HLA抗体。主要结局是长期同种异体肾移植存活率,包括对移植失败相关原因、根据原因确定的移植失败延迟时间以及移植失败的决定因素进行研究。
随访期间有732例移植失败(中位时间:4.51年),其中95.08%的失败原因已明确。移植后9年的同种异体肾移植存活率为78%。移植失败的原因包括:抗体介导的排斥反应(31.69%)、血栓形成(25.55%)、并发内科疾病(14.62%)、原发性肾病复发(7.1%)、BK或巨细胞病毒相关性肾病(n = 35,4.78%)、T细胞介导的排斥反应(4.78%)、泌尿系统疾病(2.46%)和钙调神经磷酸酶抑制剂肾毒性(1.09%)。
移植失败的主要原因是抗体介导的排斥反应和血栓形成。这些结果鼓励人们努力更早地预防和检测这些并发症,以提高移植存活率。